Drug Type Small molecule drug |
Synonyms cannabinoid+celecoxib conjugate (Enveric Biosciences), cannabinoid/celecoxib conjugate (Enveric Biosciences) |
Target |
Action agonists, inhibitors |
Mechanism CB agonists(Cannabinoid receptor agonists), COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis | Preclinical | United States | 08 Feb 2022 | |
| Pain | Preclinical | United States | - |





